Literature DB >> 9680392

Characterization of the murine TIGR/myocilin gene.

H Abderrahim1, V L Jaramillo-Babb, Z Zhou, D Vollrath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9680392     DOI： 10.1007/s003359900844

Source DB:  PubMed          Journal:  Mamm Genome        ISSN： 0938-8990            Impact factor:   2.957


× No keyword cloud information.
  7 in total

Review 1.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

2.  Efficient in vivo doxycycline and cre recombinase-mediated inducible transgene activation in the murine trabecular meshwork.

Authors:  Pu Liu; Xueyao Fu; Randy L Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-23       Impact factor: 4.799

3.  Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: an in vivo imaging and migration study.

Authors:  Joshua A Wood; Dai-Jung Chung; Shin Ae Park; Allison L Zwingenberger; Christopher M Reilly; Irene Ly; Naomi J Walker; William Vernau; Kei Hayashi; Erik R Wisner; Matthew S Cannon; Philip H Kass; Simon R Cherry; Dori L Borjesson; Paul Russell; Christopher J Murphy
Journal:  J Ocul Pharmacol Ther       Date:  2011-12-16       Impact factor: 2.671

4.  Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function.

Authors:  B S Kim; O V Savinova; M V Reedy; J Martin; Y Lun; L Gan; R S Smith; S I Tomarev; S W John; R L Johnson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  Regulation of myocilin-associated exosome release from human trabecular meshwork cells.

Authors:  Emely A Hoffman; Kristin M Perkumas; Lindsey M Highstrom; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

Review 6.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

7.  CRISPR-Cas9-based treatment of myocilin-associated glaucoma.

Authors:  Ankur Jain; Gulab Zode; Ramesh B Kasetti; Fei A Ran; Winston Yan; Tasneem P Sharma; Kevin Bugge; Charles C Searby; John H Fingert; Feng Zhang; Abbot F Clark; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.